Publications for Lars-Gunnar Arnesson
Co-author map based on ISI articles 2007-

Keywords

women tumours tumour treatment survival surgery situ rt risk recurrence radiotherapy prognostic patients interval cent cancers cancer breast axillary adjuvant

Journal Articles

B K. Linderholm, S Linder, Lars-Gunnar Arnesson and Olle Stål
  Identification of intermediate risk breast cancer patients with1-3 positive lymph nodes and excellent survival after tamoxifen as only systemic adjuvant therapy by use of markers of proliferation and apoptosis
  Breast, 2013, 22(5), 643-649.

L Holmberg, Y N S Wong, L Tabar, A Ringberg, P Karlsson, Lars-Gunnar Arnesson, K Sandelin, H Anderson, H Garmo and S Emdin
  Mammography casting-type calcification and risk of local recurrence in DCIS: analyses from a randomised study
  British Journal of Cancer, 2013, 108(4), 812-819.
   Fulltext  PDF  
 Web of Science® Times Cited: 2

Oliver Gimm, Lars-Gunnar Arnesson, Pia Olofsson, Olallo Morales and Claes Juhlin
  Super-selective venous sampling in conjunction with quickPTH for patients with persistent primary hyperparathyroidism: report of five cases
  Surgery today (Print), 2012, 42(6), 570-576.
   Fulltext  PDF  
 Web of Science® Times Cited: 1

Patrik Johansson, Helena Fohlin, Lars-Gunnar Arnesson, Monika Dufmats, Kerstin Nordenskjoeld, Bo Nordenskjöld and Olle Stål
  Improved survival for women with stage I breast cancer in south-east Sweden: A comparison between two time periods before and after increased use of adjuvant systemic therapy
  ACTA ONCOLOGICA, 2009, 48(4), 504-513.
   Fulltext  PDF  
 Web of Science® Times Cited: 2

Lars Holmberg, Hans Garmo, Bengt Granstrand, Anita Ringberg, Lars-Gunnar Arnesson, Kerstin Sandelin, Per Karlsson, Harald Anderson and Stefan Emdin
  Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast
  Journal of Clinical Oncology, 2008, 26(8), 1247-1252.
 Web of Science® Times Cited: 87

A. Ringberg, H. Nordgren, S. Thorstensson, I. Idvall, H. Garmo, B. Granstrand, Lars-Gunnar Arnesson, K. Sandelin, A. Wallgren, H. Anderson, S. Emdin and L. Holmberg
  Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast - Results from the Swedish randomised trial
  European Journal of Cancer, 2007, 43(2), 291-298.
 Web of Science® Times Cited: 30

SO Emdin, B Granstrand, A Ringberg, K Sandelin, Lars-Gunnar Arnesson, H Nordgren, H Andersson, H Garmo, L Holmberg and A Wallgren
  SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening
  Acta Oncologica, 2006, 45(5), 536-543.
 Web of Science® Times Cited: 94

G Tejler, B Norberg, Monika Dufmats, Bo Nordenskjöld and Lars-Gunnar Arnesson
  Survival after treatment for breast cancer in a geographically defined population
  British Journal of Surgery, 2004, 91(10), 1307-1312.
 Web of Science® Times Cited: 12

I Fredriksson, G Liljegren, M Palm-Sjövall, Lars-Gunnar Arnesson, SO Emdin, T Fornander, A Lindgren, H Nordgren, I Idvall, M Holmqvist, L Holmberg and J Frisell
  Risk factors for local recurrence after breast-conserving surgery
  British Journal of Surgery, 2003, 90(9), 1093-1102.
 Web of Science® Times Cited: 38

I Fredriksson, G Liljegren, Lars-Gunnar Arnesson, SO Emdin, M Palm-Sjövall, T Fornander, M Holmqvist, L Holmberg and J Frisell
  Consequences of axillary recurrence after conservative breast surgery
  British Journal of Surgery, 2002, 89(7), 902-908.
 Web of Science® Times Cited: 27

I Fredriksson, G Liljegren, Lars-Gunnar Arnesson, SO Emdin, M Palm-Sjövall, T Fornander, M Holmqvist, L Holmberg and J Frisell
  Local recurrence in the breast after conservative surgery - A study of prognosis and prognostic factors in 391 women
  European Journal of Cancer, 2002, 38(14), 1860-1870.
 Web of Science® Times Cited: 42

I Fredriksson, G Liljegren, Lars-Gunnar Arnesson, SO Emdin, M Palm-Sjovall, T Fornander, J Frisell and L Holmberg
  Time trends in the results of breast conservation in 4694 women
  European Journal of Cancer, 2001, 37(12), 1537-1544.
 Web of Science® Times Cited: 20

Askmalm Marie Stenmark-Askmalm, Massimiliano Gentile, Sten Wingren, Olle Stål and Lars-Gunnar Arnesson
  Protein accumulation and gene mutation of p53 in bilateral breast cancer
  Acta Oncologica, 2001, 40(1), 56-62.
 Web of Science® Times Cited: 8

Cecilia Gunnarsson, Birgit Olsson, Olle Stål and Lars-Gunnar Arnesson
  Abnormal expression of 17β-hydroxysteroid dehydrogenases in breast cancer predicts late recurrence
  Cancer Research, 2001, 61(23), 8448-8451.
 Web of Science® Times Cited: 72

Lars-Gunnar Arnesson and J Ahlgren
  Omitting axillary surgery for low-risk breast cancer patients. A Swedish prospective cohort study.
  Acta Oncologica, 2000, 39, 291-294.
 Web of Science® Times Cited: 5

B Vitak, K E Olsen, Jan-Christer Månson, Lars-Gunnar Arnesson and Olle Stål
  Tumour characteristics and survival in patients with invasive interval breast cancer classified according to mammographic findings at the latest screening: a comparison of true interval and missed interval cancers
  European Radiology, 1999, 9(3), 460-469.

Conference Articles

M Sundquist, Lars-Gunnar Arnesson, L Brudin, H Fohlin and G Tejler
  When do locoregional recurrencies occur and how common is contralateral breast cancer?
  in CANCER RESEARCH, vol 18, 2009.


Ph.D. Theses

Lars-Gunnar Arnesson
  Small breast cancers: Diagnosis, prognostic factors and clinical outcome in a screening population
  1994.